NO20030985L - Behandling av betennelsestilstander - Google Patents

Behandling av betennelsestilstander

Info

Publication number: NO20030985L
Authority: NO; Norway
Prior art keywords: treatment; inflammatory conditions; inflammatory; mefloquine; administration
Prior art date: 2000-09-05

Application number

NO20030985A

Other languages

English (en)

Other versions

NO323227B1 (no

NO20030985D0 (no

Inventor

Benjamin Mark Skead

Robin Mark Bannister

Alan Rothaul

Original Assignee

Arakis Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-05

Filing date

2003-03-03

Publication date

2003-03-03

2003-03-03 Application filed by Arakis Ltd filed Critical Arakis Ltd

2003-03-03 Publication of NO20030985D0 publication Critical patent/NO20030985D0/no

2003-03-03 Publication of NO20030985L publication Critical patent/NO20030985L/no

2007-02-05 Publication of NO323227B1 publication Critical patent/NO323227B1/no

Links

230000004968 inflammatory condition Effects 0.000 title 1
XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 abstract 1
208000023275 Autoimmune disease Diseases 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
229960001962 mefloquine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20030985A 2000-09-05 2003-03-03 Anvendelse av (+)-erytro-mefloquin for fremstilling av et medikament NO323227B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0021776.0A GB0021776D0 (en)	2000-09-05	2000-09-05	The treatment of inflammatory disorders
PCT/GB2001/003924 WO2002019994A2 (en)	2000-09-05	2001-08-31	The treatment of inflammatory disorders

Publications (3)

Publication Number	Publication Date
NO20030985D0 NO20030985D0 (no)	2003-03-03
NO20030985L true NO20030985L (no)	2003-03-03
NO323227B1 NO323227B1 (no)	2007-02-05

Family

ID=9898880

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030985A NO323227B1 (no)	2000-09-05	2003-03-03	Anvendelse av (+)-erytro-mefloquin for fremstilling av et medikament

Country Status (21)

Country	Link
US (2)	US7034028B2 (no)
EP (1)	EP1315496B1 (no)
JP (1)	JP2004508323A (no)
CN (1)	CN1309388C (no)
AT (1)	ATE302008T1 (no)
AU (2)	AU8423401A (no)
BR (1)	BR0113646A (no)
CA (1)	CA2419601A1 (no)
DE (1)	DE60112768T2 (no)
DK (1)	DK1315496T3 (no)
ES (1)	ES2245372T3 (no)
GB (1)	GB0021776D0 (no)
HU (1)	HUP0300934A2 (no)
IL (1)	IL154419A0 (no)
MX (1)	MXPA03001920A (no)
NO (1)	NO323227B1 (no)
NZ (1)	NZ524099A (no)
PL (1)	PL364030A1 (no)
PT (1)	PT1315496E (no)
WO (1)	WO2002019994A2 (no)
ZA (1)	ZA200301139B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0021776D0 (en) *	2000-09-05	2000-10-18	Arakis Ltd	The treatment of inflammatory disorders
GB0406014D0 (en) *	2004-03-17	2004-04-21	Arakis Ltd	Pharmaceutical composition and use
WO2006108666A1 (en) *	2005-04-13	2006-10-19	Proteosys Ag	Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
WO2008075366A2 (en) *	2006-12-20	2008-06-26	Medwell Laboratories Ltd.	Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
JP2013530244A (ja) *	2010-07-07	2013-07-25	ポリメディックス・インコーポレーテッド	免疫調節の方法
CN113578299B (zh) *	2020-04-30	2023-11-10	中国石油化工股份有限公司	一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) *	2020-12-31	2023-06-09	兰州大学	喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) *	2022-01-04	2022-07-29	南京医科大学	甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03505579A (ja) *	1988-06-30	1991-12-05	デービス，マイクル，エイチ	ヒト免疫不全ウイルス（ｈｉｖ）のインビボにおける活性の阻害方法
SK280617B6 (sk) *	1992-01-16	2000-05-16	Hoechst Aktiengesellschaft	Arylcykloalkylové deriváty, spôsob ich prípravy, f
CA2185019C (en) *	1994-03-09	2000-08-08	Pfizer Limited	Isoxazoline compounds as inhibitors of tnf release
DE69808440T2 (de)	1997-03-07	2003-07-10	Vernalis Research Ltd., Winnersh	Verwendung von (+)mefloquine zur behandlung von malaria
WO1999026627A1 (en) *	1997-11-26	1999-06-03	Cerebrus Limited	(-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
WO2000066107A2 (en)	1999-04-30	2000-11-09	Apt Pharmaceuticals, L.L.C.	Antimalarian agents for the treatment of asthma
GB0021776D0 (en) *	2000-09-05	2000-10-18	Arakis Ltd	The treatment of inflammatory disorders

2000
- 2000-09-05 GB GBGB0021776.0A patent/GB0021776D0/en not_active Ceased
2001
- 2001-08-31 EP EP01963202A patent/EP1315496B1/en not_active Expired - Lifetime
- 2001-08-31 ES ES01963202T patent/ES2245372T3/es not_active Expired - Lifetime
- 2001-08-31 IL IL15441901A patent/IL154419A0/xx unknown
- 2001-08-31 MX MXPA03001920A patent/MXPA03001920A/es active IP Right Grant
- 2001-08-31 BR BR0113646-1A patent/BR0113646A/pt not_active IP Right Cessation
- 2001-08-31 HU HU0300934A patent/HUP0300934A2/hu unknown
- 2001-08-31 PL PL01364030A patent/PL364030A1/xx not_active Application Discontinuation
- 2001-08-31 JP JP2002524479A patent/JP2004508323A/ja active Pending
- 2001-08-31 AU AU8423401A patent/AU8423401A/xx active Pending
- 2001-08-31 AT AT01963202T patent/ATE302008T1/de not_active IP Right Cessation
- 2001-08-31 CN CNB018152023A patent/CN1309388C/zh not_active Expired - Fee Related
- 2001-08-31 WO PCT/GB2001/003924 patent/WO2002019994A2/en not_active Ceased
- 2001-08-31 CA CA002419601A patent/CA2419601A1/en not_active Abandoned
- 2001-08-31 PT PT01963202T patent/PT1315496E/pt unknown
- 2001-08-31 AU AU2001284234A patent/AU2001284234B2/en not_active Ceased
- 2001-08-31 DE DE60112768T patent/DE60112768T2/de not_active Expired - Fee Related
- 2001-08-31 DK DK01963202T patent/DK1315496T3/da active
- 2001-08-31 NZ NZ524099A patent/NZ524099A/en unknown
- 2001-08-31 US US10/362,784 patent/US7034028B2/en not_active Expired - Fee Related
2003
- 2003-02-11 ZA ZA200301139A patent/ZA200301139B/en unknown
- 2003-03-03 NO NO20030985A patent/NO323227B1/no unknown
2005
- 2005-11-30 US US11/290,944 patent/US20060074106A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20060074106A1 (en)	2006-04-06
HUP0300934A2 (hu)	2003-11-28
CA2419601A1 (en)	2002-03-14
US20040029916A1 (en)	2004-02-12
AU2001284234B2 (en)	2004-11-04
CN1309388C (zh)	2007-04-11
PL364030A1 (en)	2004-12-13
DE60112768T2 (de)	2006-02-02
EP1315496A2 (en)	2003-06-04
AU8423401A (en)	2002-03-22
ZA200301139B (en)	2004-03-29
PT1315496E (pt)	2005-11-30
NO323227B1 (no)	2007-02-05
HK1054324A1 (en)	2003-11-28
JP2004508323A (ja)	2004-03-18
GB0021776D0 (en)	2000-10-18
NZ524099A (en)	2004-04-30
US7034028B2 (en)	2006-04-25
BR0113646A (pt)	2004-01-06
WO2002019994A3 (en)	2002-05-16
NO20030985D0 (no)	2003-03-03
MXPA03001920A (es)	2004-02-12
DK1315496T3 (da)	2005-11-14
EP1315496B1 (en)	2005-08-17
CN1452488A (zh)	2003-10-29
ES2245372T3 (es)	2006-01-01
ATE302008T1 (de)	2005-09-15
WO2002019994A2 (en)	2002-03-14
DE60112768D1 (de)	2005-09-22
IL154419A0 (en)	2003-09-17

Publication	Publication Date	Title
DE60123276D1 (de)	2006-11-02	Piperazinderivate zur behandlung bakterieller infektionen
NL1017508A1 (nl)	2001-09-07	Formatiebehandelingswerkwijze die vervormbare deeltjes gebruikt.
NO20041882L (no)	2004-05-07	Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
PT1147114E (pt)	2003-10-31	Novos aralquilaminas de espirofuropiridinas uteis em terapia.
DE60023043T2 (de)	2006-06-14	(S,S)-Reboxetin zur Behandlung von Inkontinenz
MXPA03002814A (es)	2003-10-14	Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
MX238203B (es)	2006-06-28	Tratamiento de semillas con combinaciones de piretrinas, piretroides y tlametoxam.
DE69927803D1 (de)	2006-03-02	Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen.
DE60139466D1 (de)	2009-09-17	Behandlung von diabetes
EA200200742A1 (ru)	2002-12-26	1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
NL1021504A1 (nl)	2003-03-25	Waterstofbehandelingsproces.
NO20030985D0 (no)	2003-03-03	Behandling av betennelsestilstander
BR0112264B1 (pt)	2012-05-15	dispositivo de tratamento de sangue.
DK1305037T3 (da)	2007-09-17	Smertestillende medikament
BR0115882A (pt)	2003-12-02	Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
TR200200278T2 (tr)	2002-06-21	Kalsilitik bileşimler
MA25852A1 (fr)	2003-07-01	Methode pour le traitement de l'inflammation.
DE50003597D1 (de)	2003-10-16	Karde.
NO20005548D0 (no)	2000-11-03	Mykobakterieinhibitorer
IS7868A (is)	2005-05-26	Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
EP1409041A4 (en)	2007-05-16	HEMOFILTRATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES RELATED TO INFLAMMATION MEDIATORS
DE60124093D1 (de)	2006-12-07	S-methyl-dihydro-ziprasidon zur Behandlung von Augenerkrankungen.
TR200003084T2 (tr)	2001-02-21	Paroxetine askorbat
ITMI20001867A0 (it)	2000-08-10	Metodo di trattamento di reflui.
IT1319665B1 (it)	2003-10-23	Addotti di corticosteroidi con polimeri polisaccaridici naturali.